5 stories found
Novo Nordisk has introduced multi-month subscription plans for its obesity drug, Wegovy, offering lower monthly pricing and expanding sales channels to include platforms like Hims and LifeMD to compete with rivals.
LifeMD shares surged following reports that Cantor Fitzgerald reiterated its Overweight rating on the company after a strong Q4 earnings report.
Smithfield Foods, Inc. has announced a dividend of $0.3125 per share.
LifeMD has outlined a target of achieving over $250 million in annualized revenue run rate by the fourth quarter of 2026, driven by record demand for GLP-1 drugs and expanded partnerships.
LifeMD has announced the appointment of Atul Kavthekar as its new Chief Financial Officer. Following the news, the company's shares experienced an uptick.